Christine Blank

September 12, 2022

Study looks at the reasons Hispanic children tend to sleep less. For some, lack of a regular bedtime could be the key.

September 08, 2022

The link between higher multiple sclerosis rates and distance from the equator has commonly been explained by vitamin D levels. A new analysis from Johns Hopkins researchers suggests the association may also be linked to healthcare spending and the resources needed to diagnose disease.

September 05, 2022

Research shows that patients with multiple sclerosis who have been treated with drugs that target CD20 B cells drugs, such as Ocrevus and Rituxan, tend to have a weak antibody response. But cellular immunity and T cells are activated. The results suggest a need for vaccines that boost T cells.

August 15, 2022

For almost all the patients with stage I or stage II disease, the cumulative incidence of CVD mortality exceeded that of classical Hodgkin lymphoma and other cancers, according to research results published in the journal Cancer.

August 05, 2022

Sandoz has filed an application for a biosimilar to the blockbuster multiple sclerosis drug. It is not clear when it will be on the market.

August 04, 2022

German company says German healthcare system is covering its digital therapeutic called Elevida, which is based on cognitive behavioral therapy.